Maintaining protection against invasive bacteria with protein–polysaccharide conjugate vaccines
Top Cited Papers
- 1 March 2009
- journal article
- Published by Springer Nature in Nature Reviews Immunology
- Vol. 9 (3) , 213-220
- https://doi.org/10.1038/nri2494
Abstract
Polysaccharide-encapsulated organisms are the leading cause of bacterial meningitis and pneumonia in children. The use of protein-polysaccharide conjugate vaccines in developed countries over the past two decades has markedly decreased the burden of disease and mortality from these organisms through direct protection of the immunized and through herd immunity. In the next decade, the widespread use of conjugate vaccines in the developing world should prevent millions of deaths. In this Science and Society article, we describe how vaccine-induced immunity wanes rapidly after vaccination in early childhood and argue that strategies that sustain protection in the population must be considered.Keywords
This publication has 66 references indexed in Scilit:
- Type I Streptococcus pneumoniae carbohydrate utilizes a nitric oxide and MHC II‐dependent pathway for antigen presentationImmunology, 2009
- Seroprotection against serogroup C meningococcal diseaseBMJ, 2008
- Seroprotection against serogroup C meningococcal disease in adolescents in the United Kingdom: observational studyBMJ, 2008
- Impact of Meningococcal Serogroup C Conjugate Vaccines on Carriage and Herd ImmunityThe Journal of Infectious Diseases, 2008
- Serotype-Specific and Age-Dependent Generation of Pneumococcal Polysaccharide-Specific Memory B-Cell and Antibody Responses to Immunization with a Pneumococcal Conjugate VaccineClinical and Vaccine Immunology, 2008
- Immunogenicity of a Fourth Dose of Haemophilus influenzae Type b (Hib) Conjugate Vaccine and Antibody Persistence in Young Children from the United Kingdom Who Were Primed with Acellular or Whole-Cell Pertussis Component-Containing Hib Combinations in InfancyClinical and Vaccine Immunology, 2007
- Herd immunity and pneumococcal conjugate vaccine: A quantitative modelVaccine, 2007
- Human blood IgM "memory" B cells are circulating splenic marginal zone B cells harboring a prediversified immunoglobulin repertoireBlood, 2004
- Validation of Serological Correlate of Protection for Meningococcal C Conjugate Vaccine by Using Efficacy Estimates from Postlicensure Surveillance in EnglandClinical and Vaccine Immunology, 2003
- Comparative trial in infants of four conjugate Haemophilus influenzae type b vaccinesThe Journal of Pediatrics, 1992